Do not let the business change crisis.docVIP

 PAGE \* MERGEFORMAT 5 Do not let the business change crisis Overall limit of antibiotics in the domestic pharmacies selling process, usually people are not familiar with or do not like to use some of the proprietary Chinese medicines, antibiotics into the ranks of a sudden. Sales of antibiotics meet resistance, no doubt ‘exposing’ a huge market space. However, many companies are aware that traditional Chinese medicine, antibiotics limit the loss of sales in bringing the same time, also brought opportunities. Recently, domestic manufacturers have a large number of traditional Chinese medicine into the antibiotic market, anti-bacterial anti-inflammatory launched in the fields of Chinese medicine to the Western EU. Guilin Sanjin Pharmaceutical official said that in the next 3-5 years, will invest a billion dollars of funds to develop anti-bacterial anti-inflammatory proprietary Chinese medicines, and use it as a breakthrough to challenge the dominance of Western medicine. The Guangzhou Baiyun Mountain in the pharmaceutical companies took the lead shot into the ‘medicine of antibiotics’, investment 60 million yuan and Guangzhou University of Chinese Medicine build a anti-bacterial anti-inflammatory lab, Guangzhou Wong Lo Kat, King Sau Hall, Beijing Tong Ren Tang and other long-established pharmaceutical companies have also introduced the concept of that there is much exert its utmost to trend. According to an incomplete statistics, there are several hundred enterprises in the Chinese medicine market, worked hard for antibiotics. However, traditional Chinese medicine enterprises to enter the highly competitive market segment is no small task of antibiotics? Only brand that hurdle, and had a lower test of differentiation of Chinese medicine business. To this end, some traditional Chinese medicine companies quickly adjust strategies. As the oral drugs such as throat ‘boss’ in Guilin three gold, the national food safety regulator is now an urgent application to the